Boule Diagnostics AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	489.7	558.46	571.33	548.09	463.34
Revenue Growth (YoY)	-12.31%	-2.25%	4.24%	18.29%	15.70%
Cost of Revenue	275.9	303.33	321.62	320.18	264.71
Gross Profit	213.8	255.13	249.71	227.91	198.64
Selling, General & Admin	129.7	146.89	153.35	143.6	120.15
Research & Development	58.9	37.8	53.09	51.57	43.33
Other Operating Expenses	-2.4	-	-	-0.74	-0.7
Operating Expenses	186.2	184.69	206.44	194.43	162.78
Operating Income	27.6	70.44	43.27	33.48	35.86
Interest Expense	-16.3	-12.59	-11.3	-9.85	-5.49
Interest & Investment Income	1.5	1.39	1.14	1.78	1.35
Currency Exchange Gain (Loss)	-	-6.48	-3.01	-4.5	-2.95
Other Non Operating Income (Expenses)	-	0	0	-0	-0
EBT Excluding Unusual Items	12.8	52.77	30.1	20.9	28.77
Merger & Restructuring Charges	-	-22.8	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	-0.05	-
Asset Writedown	-6.9	-390.72	-	-	-
Pretax Income	5.9	-360.75	30.1	20.85	28.77
Income Tax Expense	9.7	-64.17	5.12	8.12	5.5
Net Income	-3.8	-296.58	24.98	12.73	23.27
Net Income to Common	-3.8	-296.58	24.98	12.73	23.27
Net Income Growth	-	-	96.24%	-45.31%	-
Shares Outstanding (Basic)	38	39	39	28	27
Shares Outstanding (Diluted)	38	39	39	28	27
Shares Change (YoY)	-2.15%	-	36.37%	4.65%	40.14%
EPS (Basic)	-0.10	-7.64	0.64	0.46	0.87
EPS (Diluted)	-0.10	-7.64	0.64	0.45	0.86
EPS Growth	-	-	42.22%	-47.67%	-
Free Cash Flow	-2.7	37.68	44.51	-17.79	40.14
Free Cash Flow Per Share	-0.07	0.97	1.15	-0.63	1.48
Dividend Per Share	-	-	-	-	0.550
Gross Margin	43.66%	45.68%	43.71%	41.58%	42.87%
Operating Margin	5.64%	12.61%	7.57%	6.11%	7.74%
Profit Margin	-0.78%	-53.11%	4.37%	2.32%	5.02%
Free Cash Flow Margin	-0.55%	6.75%	7.79%	-3.25%	8.66%
EBITDA	44	87.53	60.41	54.14	51.17
EBITDA Margin	8.98%	15.67%	10.57%	9.88%	11.04%
D&A For EBITDA	16.4	17.09	17.14	20.66	15.31
EBIT	27.6	70.44	43.27	33.48	35.86
EBIT Margin	5.64%	12.61%	7.57%	6.11%	7.74%
Effective Tax Rate	164.41%	-	17.02%	38.95%	19.11%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.